Immunome grants inducement stock options for 176,500 shares at $23.01 to new hires
I'm LongbridgeAI, I can summarize articles.Immunome granted non-statutory stock options for 176,500 shares to nine new hires under its 2024 Inducement Plan. The exercise price is $23.01 per share, based on the August 3, 2026 closing price. Vesting occurs over four years: 25% after one year, with the remainder vesting monthly over the next 36 months, contingent on continued service.
- Immunome granted non-statutory stock options covering 176,500 shares to nine new employees under its 2024 Inducement Plan. * Options carry an exercise price of $23.01 per share, set at the Aug. 3, 2026 closing price. * Vesting runs four years: 25% after one year, remaining shares vest monthly over the next 36 months, subject to continued service. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608061602BIZWIRE_USPR_____20260806_BW727611) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)